The Board of Directors of Icure Pharmaceutical Incorporation has authorized a buyback plan on February 25, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,848 KRW | -0.75% | -2.74% | -11.58% |
1st Jan change | Capi. | |
---|---|---|
-11.58% | 50.98M | |
-1.70% | 254B | |
+13.66% | 19.89B | |
0.00% | 18.26B | |
+1.41% | 11.16B | |
-7.41% | 10.38B | |
+16.34% | 7.63B | |
+16.25% | 5.97B | |
+2.25% | 4.65B | |
-16.82% | 3.81B |
- Stock Market
- Equities
- A175250 Stock
- News Icure Pharmaceutical Incorporation
- Icure Pharmaceutical Incorporation authorizes a Buyback Plan.